Scientists Discovered a Mushroom That's Both Toxic and Trippy
Scientists discovered a mushroom in Florida that contains both toxic and psychedelic compounds
14 trends tracked about this subject — the full history, oldest to newest below.
Scientists discovered a mushroom in Florida that contains both toxic and psychedelic compounds
Usona has filed a New Drug Application for its psilocybin depression treatment, intensifying the competitive race with Compass Pathways for FDA approval.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent studies in PsyPost, BBC Wildlife Magazine, and Nature examine how psychedelics like LSD and psilocybin transform the brain.
Researchers have discovered that a compound found in magic mushrooms may block severe chemotherapy-induced pain in mice.
Early study findings indicate psilocybin may protect patients against a common and debilitating side effect of chemotherapy treatment.
Preclinical models demonstrate that psilocybin prevents chemotherapy-related nerve injury and associated symptoms, according to UT MD Anderson.
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
The world's largest single-site study on psilocybin has identified a 'hidden order' within the brain's activity during psychedelic experiences.
New research suggests that a single dose of magic mushrooms can fundamentally reshape brain function and neural activity long after the experience ends.
Compass Pathways' psilocybin depression therapy shows six‑month durability, sparking market optimism.
A medical report detailing a woman with advanced Alzheimer's regaining speech and mobility after psilocybin use is sparking new scientific inquiry.
A single case study documents temporary memory and speech recovery in an 80-year-old patient following a high dose of psilocybin.